JNP
Juniper Pharmaceuticals, Inc. Common Stock
JNP
JNP
Delisted
JNP was delisted on the 13th of August, 2018.
38 hedge funds and large institutions have $13.5M invested in Juniper Pharmaceuticals, Inc. Common Stock in 2014 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 11 reducing their positions, and 4 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
63% less call options, than puts
Call options by funds: $132K | Put options by funds: $356K
Holders
38
Holding in Top 10
–
Calls
$132K
Puts
$356K
Top Buyers
| 1 | +$418K | |
| 2 | +$339K | |
| 3 | +$193K | |
| 4 |
PP
PDT Partners
New York
|
+$94K |
| 5 |
RCM
Rotella Capital Management
Bellevue,
Washington
|
+$91K |
Top Sellers
| 1 | -$201K | |
| 2 | -$115K | |
| 3 | -$110K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$97K |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
-$58.5K |